SCI-induced deficits in antiviral immunity: The role of sTNF.

SCI 引起的抗病毒免疫缺陷:sTNF 的作用。

基本信息

  • 批准号:
    10019418
  • 负责人:
  • 金额:
    $ 49.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-30 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract Individuals suffering from chronic neurological disorders, such as spinal cord injury (SCI), are at greater risk of serious life-threatening complications from infections, including Influenza A virus (IAV) and pneumonia. Infections are the leading cause of re-hospitalization and mortality in patients living with chronic SCI. Therefore, reducing complications from infections is critical for improving the health and life span of SCI patients. Several groups, including ours, have endeavored to uncover the mechanisms underlying SCI-induced immune depression. For example, high-thoracic (T3) SCI disrupts sympathetic regulation of lymphoid organs and leads to impaired antibody synthesis and increased splenocyte apoptosis. Elegant studies by Ueno and colleagues demonstrated that high-thoracic SCI-induced immune dysfunction is due, in large part, to massive reorganization of the spinal sympathetic reflex circuit, e.g. the recruitment of glutamatergic interneurons, that results in increased sensitivity of this circuit. Silencing these glutamatergic interneurons restored immune balance, in the absence of pathogen challenge, demonstrating that immune balance can be affected by neurogenic mechanisms. However, the mediator(s) of pathological plasticity and glutamatergic interneuron activation post-SCI have not been established. We have exciting preliminary data suggesting that inhibiting soluble Tumor Necrosis Factor (sTNF) in the spinal cord following SCI: attenuates neuroinflammation and aberrant neuronal plasticity and activation, reduces immune dysfunction, and improves antiviral immunity (reduced viral load, increased specific CD8 T cells). Collectively, these data provide for a strong scientific premise to explore the role of sTNF in SCI- induced immune dysfunction. We hypothesize that heightened levels of sTNF in the spinal cord after injury play a crucial role in triggering robust neuroinflammation (e.g., NF-kB activation) and aberrant plasticity that, in turn, lead to hyperactivity of sympathetic circuitry after SCI and peripheral immune dysfunction. These important findings highlight the role of local sTNF signaling in influencing peripheral immunity. Based upon these data, in the following specific aims, we will: Aim 1: Determine the extent that sTNF/TNFR1 signaling in neurons contributes to immune depression following SCI. Aim 2: Investigate the contribution of sTNF to extrinsic (peripheral) factors of impaired antiviral immune responses in chronic SCI mice.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John Roland Bethea其他文献

John Roland Bethea的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John Roland Bethea', 18)}}的其他基金

TNFR2 Sex Differences and EAE
TNFR2 性别差异和 EAE
  • 批准号:
    10384115
  • 财政年份:
    2021
  • 资助金额:
    $ 49.2万
  • 项目类别:
TNFR2 Sex Differences and EAE
TNFR2 性别差异和 EAE
  • 批准号:
    10532717
  • 财政年份:
    2021
  • 资助金额:
    $ 49.2万
  • 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
  • 批准号:
    10207806
  • 财政年份:
    2019
  • 资助金额:
    $ 49.2万
  • 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
  • 批准号:
    10441446
  • 财政年份:
    2019
  • 资助金额:
    $ 49.2万
  • 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
  • 批准号:
    10657427
  • 财政年份:
    2019
  • 资助金额:
    $ 49.2万
  • 项目类别:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
可溶性 TNFa 在脊髓损伤后自主神经反射异常发展中的作用
  • 批准号:
    10386794
  • 财政年份:
    2018
  • 资助金额:
    $ 49.2万
  • 项目类别:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
可溶性 TNFa 在脊髓损伤后自主神经反射异常发展中的作用
  • 批准号:
    9902562
  • 财政年份:
    2018
  • 资助金额:
    $ 49.2万
  • 项目类别:
Enhancing supraspinal plasticity to improve functional recovery after SCI
增强脊髓上可塑性以改善 SCI 后的功能恢复
  • 批准号:
    9976601
  • 财政年份:
    2017
  • 资助金额:
    $ 49.2万
  • 项目类别:
Enhancing supraspinal plasticity to improve functional recovery after SCI
增强脊髓上可塑性以改善 SCI 后的功能恢复
  • 批准号:
    9193741
  • 财政年份:
    2016
  • 资助金额:
    $ 49.2万
  • 项目类别:
Astrocytes Play a Critical Role in the Pathology of EAE
星形胶质细胞在 EAE 病理学中发挥关键作用
  • 批准号:
    8824782
  • 财政年份:
    2009
  • 资助金额:
    $ 49.2万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 49.2万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 49.2万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 49.2万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.2万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 49.2万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 49.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 49.2万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 49.2万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 49.2万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 49.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了